Average Co-Inventor Count = 3.44
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (17 from 1,777 patents)
2. A/s Ferrosan (5 from 41 patents)
3. High Point Pharmaceuticals, LLC (3 from 50 patents)
4. Novo Nordiskals (1 from 10 patents)
5. Novo Nordisk Ais (1 from 1 patent)
27 patents:
1. 8022066 - 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes
2. 7939690 - Haloalkylsulfone substituted compounds useful for treating obesity and diabetes
3. 7915299 - 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
4. 6329367 - Fused 1,2,4-thiadiazine derivatives, their preparation and use
5. 6242443 - 1,2,4-benzothiadiazine derivatives, their preparation and use
6. 6225310 - Fused 1,2,4-thiadiazine derivatives, their preparation and use
7. 6001832 - [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and
8. 5889002 - Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their
9. 5792764 - Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their
10. 5559106 - Heterocyclic compounds, their use and preparation
11. 5532236 - [1,2,4]triazolo[4,3-a]quinoxaline compounds
12. 5504085 - Triazolo quinoxalines and their preparation and use
13. 5308845 - Quinoxaline compounds and their preparation and use
14. 5182279 - Benzothienopyrazinedione compounds and their preparation and use
15. 5153195 - Quinoxaline compounds and their preparation and use